It was an unforgettable weekend in Miami at #ASPN2024! A sincere thank you to the American Society of Pain and Neuroscience ASPN for bringing together thought leaders and innovators from across the globe. Thank you to everyone who stopped by the Nevro booth or attended one of our customer dinners to learn more about Nevro and our AI-driven SCS Innovations & Comprehensive SI Joint Solutions. We are grateful for our physician and APP partners whose support drives our mission forward. A special thank you to Drs. Ashley Bailey-Classen, DO, Alexander Escobar, M.D., Warren Grace III, M.D., Kristen Klein NP, and Dr. Usman Latif, for your partnership and education on behalf of Nevro. Nevro appreciates the opportunity to participate in the ASPN annual conference, and we look forward to the next one! #NevroHFXiQ #NevroSIJoint
Nevro
Medical Equipment Manufacturing
Redwood City, California 64,064 followers
We Believe True Innovation Transforms More Lives
About us
Nevro is a global medical device company focused on delivering innovation to improve the quality of life for patients suffering from debilitating chronic pain. Through Nevro's pain management solutions, Nevro | HFX and Nevro | SI Joint, Nevro brings together enduring technologies, optimized therapies, and individualized patient support, all built on a foundation of proof that results in a comprehensive solution to relieve the burden of pain for more patients. HFX is a comprehensive solution that includes a Senza Spinal Cord Stimulation system and support services for the treatment of chronic pain, including painful diabetic neuropathy when programmed with a frequency of 10 kHz. Nevro | SI Joint includes the Nevro1™ SI joint fusion system with integrated transfixing technology provides immediate stabilization with opportunity for long-term fusion and pain relief through a posterior minimally invasive surgical (MIS) approach.
- Website
-
https://www.nevro.com
External link for Nevro
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Redwood City, California
- Type
- Public Company
- Founded
- 2006
Locations
-
Primary
1800 Bridge Parkway
Redwood City, California 94065, US
Employees at Nevro
Updates
-
New publication alert! David Provenzano and Jozef Leech ’s innovative analysis was recently published in Neuromodulation, “Defining Short- and Long-Term Programming Requirements in Patients Treated With 10-kHz Spinal Cord Stimulation”. This study tells: “To our knowledge, this study is the first real-world, single-center study to provide a detailed, longitudinal view of 10-kHz SCS programming; 10-kHz SCS is an effective therapy for the treatment of chronic pain, with a high responder rate achieved with minimal required Device Programming during both trial and post permanent implant phase” Read the full study here: https://lnkd.in/grc3numA
-
Recently, our US Sales Excellence team got together to strengthen team culture and re-brand the team’s efforts, programs, and support roles. This led to a workshop on accelerating the strategic learning plan to better deliver against the needs of our Nevro US Sales Team, healthcare professional partners, and most importantly the patients we serve. At this meeting they discussed the diverse and unique strengths to achieve unified goals, adult learning & development strategies, and short term & long term evolution of our training programs. Our US Sales Excellence team leads the learning and development effort for all field personnel, from new hire onboarding, to field training, ongoing training initiatives, and our management development program. This year the team has trained over 100 Nevro US Sales team members, so far, either new to role or Nevro. If you’re interested in joining the Nevro Sales Team, and working directly with this team, check out our careers page: https://lnkd.in/g3T4vNAA #Nevro #SalesExcellence #Sales John Logeman Jordonna Asbridge Heather Steffen Daniel Balkcom
-
Are you currently in Miami and attending the 6th Annual ASPN conference? Have you checked out our booth yet? Come say hello and see our latest innovations. #NevroHFX #NevroSIJoint #HFXiQ #Nevro1
-
Are you planning out your schedule for this weekend's American Society of Pain and Neuroscience ASPN? Please join Dr. Erika Petersen the morning of Sunday, 7/14, to hear her discussion on “Quality-of-life and HbA1c continue to improve at 4 years post-implant in patients with painful diabetic neuropathy treated with 10kHz spinal cord stimulation.” #ASPN2024 #SCS #NevroHFX
-
🌟 Value Recognition Spotlight: One Team 🌟 We are excited to recognize Gerd Gottschalk and Mareen Rensing for embodying the value of One Team at Nevro. Their dedication and commitment to this value have made a significant impact on our team and organization. Gerd and Mareen's actions reflect our core values and inspire us all to strive for excellence. Join us in celebrating their outstanding contributions to our team and culture! As part of our ongoing commitment to fostering a culture of recognition, today we are launching a new rewards and recognition platform that will further elevate and celebrate our team's achievements! 🌟 #TeamNevro #NevroAchievers #EmployeeRecognition #OneTeam
-
This year at American Society of Pain and Neuroscience ASPN, be sure to check out our latest clinical research and evidence around 10 kHz Therapy™ and Nevro1™ SI Joint fusion technology! #ASPN2024 #SCS #SIJoint
-
We're getting ready to head to Miami for the 6th American Society of Pain and Neuroscience ASPN Annual Conference! Come get hands on experience with Nevro’s products including HFX iQ™ and Nevro1™ at Booth 157! #ASPN2024 #Nevro1 #SIJoint #SIJointFusion #NevroHFX #HFXiQ
-
Here at Nevro, we hold ourselves to six values ⭐ One Team ⭐ Patients First ⭐ Ownership ⭐ Elevate Diversity ⭐ Courageous Leadership ⭐ Do the Right Thing We are excited to highlight our team members who exemplify these values and celebrate their excellent accomplishments, as shared by their peers. #TeamNevro #EmployeeRecognition
-
We applaud the Washington State Healthcare Authority’s (HCA) Health Technology Assessment (HTA) resulting in a new coverage determination of spinal cord stimulation (SCS). This decision enables access to SCS therapy for state employees, Medicaid recipients, and individuals with worker’s compensation coverage. SCS helps treat low back pain, failed back surgery syndrome (persistent lower back pain experienced post spine surgery), or painful diabetic peripheral neuropathy (a debilitating complication of diabetes). This was a collective effort from the passionate advocacy of local physicians, the North American Neuromodulation Society (NANS) in collaboration with many additional physician societies, and companies that develop this technology for people living with chronic pain. To learn more about this program, please visit: https://lnkd.in/gf2SSMvb
Similar pages
Browse jobs
Stock
NVRO
NYSE
20 minutes delay
$10.10
0.56 (5.87%)
- Open
- 9.64
- Low
- 9.64
- High
- 10.21
Data from Refinitiv
See more info on